Ron Scarboro

CEO, Azurity Pharmaceuticals

Articles by Ron Scarboro

CPHI Milan: Medication Non-Adherence Is a Design Problem

ByRon Scarboro,Christopher Cole,Zachary Zubulake

October 1st 2026

Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.

Ron Scarboro

Articles by Ron Scarboro

CPHI Milan: Medication Non-Adherence Is a Design Problem

Latest Updated Articles

Trending on Pharmaceutical Technology

Tavapadon Sets Development Benchmark for Parkinson's

AAPS PharmSci 360: CMC Strategies, Part 3

CPHI Milan 2026: Digital Supply Chains

KRAS G12D Inhibitor's $2.13B Deal Tests Cross-Border Tech Transfer

Companies Launching Equipment and Services at CPHI Milan 2026